Xiaopei Hao
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Xuehao Wang (11 shared papers)Weiwei Tang (9 shared papers)Dawei Rong (7 shared papers)Zhiying Zheng (4 shared papers)Guangshun Sun (5 shared papers)Hanyuan Liu (4 shared papers)Yao Zhang (2 shared papers)Guoqiang Sun (2 shared papers)
- Journals
- International Journal of Biological Sciences (2 papers)Cancer Letters (2 papers)iScience (1 paper)Journal of Hepatology (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaSouth KoreaAustralia
In The Last Decade
Xiaopei Hao
16 papers receiving 607 citations
Xiaopei Hao's Hit Papers
Peers
Comparison fields: 5 of 52
- Cancer Research 277
- Immunology 169
- Pulmonary and Respiratory Medicine 211
- Hepatology 50
- Oncology 155
Countries citing papers authored by Xiaopei Hao
This map shows the geographic impact of Xiaopei Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopei Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopei Hao more than expected).
Fields of papers citing papers by Xiaopei Hao
This network shows the impact of papers produced by Xiaopei Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopei Hao. The network helps show where Xiaopei Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaopei Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing Hit paper breakdown → | 2022 | 194 |
| 2 | 2021 | 110 | |
| 3 | 2021 | 77 | |
| 4 | 2022 | 70 | |
| 5 | 2022 | 57 | |
| 6 | 2022 | 23 | |
| 7 | 2024 | 20 | |
| 8 | 2023 | 17 | |
| 9 | 2024 | 10 | |
| 10 | 2021 | 9 | |
| 11 | E2F1-mediated GINS2 transcriptional activation promotes tumor progression through PI3K/AKT/mTOR pathway in hepatocellular carcinoma. | 2022 | 7 |
| 12 | 2024 | 6 | |
| 13 | 2025 | 4 | |
| 14 | 2019 | 3 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 |
About Xiaopei Hao
Xiaopei Hao is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 17 papers that have together received 609 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers), RNA modifications and cancer (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (277 citations), Immunology (169 citations), Pulmonary and Respiratory Medicine (211 citations), Hepatology (50 citations) and Oncology (155 citations). Xiaopei Hao has collaborated with scholars based in China, South Korea and Australia. Frequent co-authors include Xuehao Wang, Weiwei Tang, Dawei Rong, Zhiying Zheng, Guangshun Sun, Hanyuan Liu, Yao Zhang, Guoqiang Sun, Haibo Yu and Guangshun Sun. Their work appears in journals such as International Journal of Biological Sciences, Cancer Letters, iScience, Journal of Hepatology and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.